Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2002
10/10/2002WO2002046373A8 Method of collecting placental stem cells
10/10/2002WO2002015915A3 Method for inducing an anti-tumor and anti-cachexia immune response in mammals
10/10/2002WO2002013809A3 Compositions containing hypotriglyceridemically active stilbenoids
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001093845A3 Carboxyalkylether-acat inhibitor combinations
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001072728A9 Novel piperazine derivatives
10/10/2002US20020147351 Lactonization process
10/10/2002US20020147336 Glucocorticoid receptor modulators
10/10/2002US20020147237 Preservation of bodily protein
10/10/2002US20020147233 Epoxyvibsanin B
10/10/2002US20020147231 Allosteric adenosine receptor modulators
10/10/2002US20020147224 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/10/2002US20020147209 Cycloalkano-indole and -azaindole derivatives
10/10/2002US20020147200 Central nervous system disorders; antiserotonine agents
10/10/2002US20020147198 Substituted arylamine derivatives and methods of use
10/10/2002US20020147195 Piperidine derivatives and anti-platelet agents containing the same
10/10/2002US20020147192 Viricides; antiinflammatory agents; antiallergens; antiarthritic agents
10/10/2002US20020147188 Protease inhibitors
10/10/2002US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002US20020147184 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
10/10/2002US20020147157 Combination therapy comprising anti-diabetic and anticonvulsant agents
10/10/2002US20020147156 Cellular uptake of bioactive agents
10/10/2002US20020147144 Prevention, therapy autoimmune diseases; anticholesterol agents
10/10/2002US20020147142 Methods and reducing or maintaining reduced levels of blood lipids using OB protein compositions
10/10/2002US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002US20020146792 Nucleotide sequences coding protein for use in the treatment of atherosclerosis
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146502 Sorbic acid as growth-stabilizing addition to feedstuffs for agricultural livestock rearing
10/10/2002US20020146474 For prophylaxis and therapy of cellulite and localized dermal excess adipose, for treating obesity
10/10/2002US20020146468 Therapy and prophylaxis of diabetes by administering to a human or animal an effective dosage of an extract of plant of the genus Trichocaulon or of the genus Hoodia
10/10/2002US20020146466 Solid form compositions containing an extract of a raw material as the active ingredient and process of preparing the same
10/10/2002US20020146463 Useful as food additives or in medicaments
10/10/2002US20020146454 Active compound is prepared in aqueous solution/ suspension; sprayed onto neutral excipients, without isolating active compound as solid substance, and dried in parallel with this, or, mixing with binder granulating with excipients and drying
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002US20020146386 In vivo use of water absorbent polymers
10/10/2002DE10117183A1 Verwendung von substituierten Imidazo[1,2-a]-pyridinverbindungen als Arzneimittel Use of substituted imidazo [1,2-a] -pyridinverbindungen as medicaments
10/10/2002DE10115922A1 Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Cyclic substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
10/10/2002DE10114178A1 Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität Zinc-free and low-zinc insulin preparations with improved stability
10/10/2002CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442674A1 Phosphoprotein target for insulin and its antagonists
10/10/2002CA2442532A1 Colloidal suspension of nanoparticles based on an amphiphilic copolymer
10/10/2002CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002CA2442370A1 Methods for increasing serotonin levels by administering (-)-hydroxycitric acid
10/10/2002CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002CA2442263A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002CA2442177A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002CA2442150A1 Sapogenin derivatives, their synthesis and use, and methods based upon their use
10/10/2002CA2442106A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002CA2442064A1 G-protein coupled receptors
10/10/2002CA2442062A1 Secreted proteins
10/10/2002CA2441252A1 Estrogen replacement therapy
10/10/2002CA2440430A1 Low glycemic response compositions
10/10/2002CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/09/2002EP1247865A2 Antibody for use in therapy
10/09/2002EP1247860A1 Crystal structure of pyruvate dehydrogenase kinase 2 (PDHK-2) and use thereof in methods for identifying and designing new ligands
10/09/2002EP1247809A2 Triazine compounds useful as sorbitol dehydrogenase inhibitors
10/09/2002EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002EP1246932A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002EP1246821A2 Process for the preparation of paroxetine and synthetic intermeditates thereof
10/09/2002EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002EP1246804A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor
10/09/2002EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246792A1 Compounds and compositions for delivering active agents
10/09/2002EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002EP1246789A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors
10/09/2002EP1246692A1 Templating of solid particles by polymer multilayers
10/09/2002EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
10/09/2002EP1246634A1 Methods for treating pancreatic disorders
10/09/2002EP1246632A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses
10/09/2002EP1246626A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance
10/09/2002EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1246538A1 Thickened oil compositions of edible oil
10/09/2002EP1049467B1 Celecoxib compositions
10/09/2002EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002EP0838473B1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/09/2002EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder
10/09/2002EP0683774B1 Hypolipidaemic compounds
10/09/2002CN1373763A Pteridinones and kinase inhibitors
10/09/2002CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002CN1373753A Mutual salt of amlodipine and atorvastatin
10/09/2002CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002CN1373659A Solid lipid formulations
10/09/2002CN1373656A Dispersion formulations contg. lipase inhibitors
10/09/2002CN1373127A Crystal choline ascorbate
1 ... 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 ... 1298